ENTX - Company ID 0001638097
The table below shows Entera Bio Ltd.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.31M | $4.14M | $8.57M | $10.86M | $12.57M | $6.92M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | $0.00 | $0.00 | $126.00K | $42.00K |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $18.90M |
| $12.49M |
| $17.01M |
| $19.31M |
| $21.22M |
| $7.34M |
| Property, plant & equipment | $121.00K | $127.00K | $114.00K | $79.00K | $57.00K | $65.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $19.48M | $13.13M | $17.41M | $19.67M | $21.60M | $7.74M |
| Accounts payable | $575.00K | $274.00K | $216.00K | $383.00K | $134.00K | $184.00K |
| Total current liabilities | $2.10M | $1.58M | $1.57M | $1.84M | $1.62M | $1.11M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $12.21M | $2.44M | $2.17M | $2.41M | $2.22M | $1.29M |
| Retained earnings | -$136.18M | -$128.87M | -$122.35M | -$119.15M | -$116.49M | -$111.57M |
| Total equity | $7.27M | $10.69M | $15.23M | $17.26M | $19.38M | $6.45M |